COMPANY PROFILE

SGI DNA

Explore full profile

A variety of synthetic genomic solutions to advance your research

San Diego, United StatesFounded 2013Biotech & Life Sciences

Valuation $100–250M Last recorded · 2019

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About SGI DNA

SGI-DNA, operating in the synthetic biology market, offers automated DNA synthesis and biologics discovery solutions. The company's flagship product, the BioXp 3200 system, allows scientists to build genes, clones, and libraries efficiently. SGI-DNA serves clients in clinical applications, including neoantigen development, vaccine development, immune monitoring, and regenerative medicine. The business model revolves around selling benchtop reagents, assembly kits, and advanced competent cells, generating revenue through product sales and specialized services. The company targets researchers and institutions in the fields of antibody engineering, genome editing, and metabolic engineering. SGI-DNA's technology enables rapid iteration and discovery, making significant strides in personalized medicine and distributed vaccine manufacturing.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2013
Headquarters: San Diego, United States
Employees: 146
Open positions: None listed
Dealroom signal: 24.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Market Intelligence, Biotechnology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2019	$25M	$100M	BroadOak Capital Partners · Northpond Ventures	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

SGI DNA website traffic

Latest recorded traffic for SGI DNA is 2K monthly website visits, up 66.7% over the last three months. SGI DNA's team grew 0% over the past year.

Latest monthly visits2K 3-month web change+66.7% 1-year team growth0%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GAGenetic AnalysisGenetic Analysis has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances	Oslo, Norway	Operational	19	$2.6M	$2.1M
FIFitgenesAustralian organization that delivers personalized, genome-based health and wellness programs	Brisbane, Australia	Operational
OTOthramOthram operates at the intersection of molecular biology, population genetics, and bioinformatics	Spring, United States	Operational
DGDatar GeneticsCutting edge European Technology in genetic sequencing and analysis	Chennai, India	Operational
ANAnchorDxAnchorDx is a precision medicine firm	Guangzhou, China	Operational
GEGeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world	Cambridge, United Kingdom	Operational
AGAtossa GeneticsHealthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients	Seattle, United States	Operational
GEGencoveDedicated to making genomic data more accessible and interpretable through molecular and software tools	New York City, United States	Operational